经尿道等离子电切联合术后吡柔比星膀胱灌注治疗腺性膀胱炎

Transurethal plasmakinetic resection combined with postoperative bladder perfusion of pirarubicin for glandular cystitis

目的：探讨经尿道等离子电切联合术后吡柔比星膀胱灌注治疗腺性膀胱炎的临床疗效。方法回顾性分析46例腺性膀胱炎患者的临床资料，先经膀胱镜检查并取活检病理证实，等离子电切镜下行病灶切除术，术后采用吡柔比星膀胱灌注化疗，1次／周，共8次，以后1次／月，共8次，定期行膀胱镜检查。结果46例均手术成功，术中无严重出血、水中毒和膀胱穿孔等并发症发生。术后随访10～24个月，其中33例治愈，7例症状缓解，6例复发。结论经尿道等离子电切联合术后吡柔比星膀胱灌注治疗腺性膀胱炎疗效确切、并发症少、复发率低，值得临床推广。

Objective To explore the treatment of transurethal plasmakinetic resection combined with postoperative bladder perfusion of pirarubicin for glandular cystitis. Methods The clinical data of 46 patients with benign prostatic hyperplasia were analyzed retrospectively. Patients were checked by cystoscopy and diagnosed by biopsy received plasmakinetic resection. All the patients were given pirarubicin perfusion 8 times once per week , followed by 8 times once per month. In addition,cystoscopy were performed regularly on patients to check. Results Operations were performed on 46 patients successfully without serious complications such as bleeding, water intoxication and bladder perforation in 46 patients. After follow-up for 10-24 months,33 patients were cured,7 patients achieved improvement and 6 patients underwent recurrence. Conclusion Plasmakinetic superpulse transurethral resection combined with postoperative baldder perfusion of pirarubicin in the treatment of glandular cystitis is effective;with less complications,lower recurrence,and worth of the clinical promotion.